This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Northwestern University, Massachusetts Institute of Technology. Active years: 2015-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Evanston, IL (US) (2015)
- Cambridge, MA (US) (2022 - 2023)
Company Filing History:
2 out of 2,220 
1 out of 8,594 
Years Active: 2015-2023
Title: Innovations and Contributions of Inventor Liangliang Hao
Introduction
Liangliang Hao is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of cancer detection and treatment. With a total of three patents to his name, Hao has made strides in developing innovative technologies that enhance the understanding and management of cancer.
Latest Patents
One of Hao's latest patents focuses on "Sensors for detecting and imaging of cancer metastasis." This invention relates to compositions and methods for the detection, classification, and treatment of cancer. It includes protease imaging sensors that are designed to release detectable markers when exposed to specific enzymes present in cancer. This technology also encompasses methods for monitoring tumor progression based on the detection of these markers in samples from subjects administered with the sensors.
Another notable patent is titled "Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates." This invention addresses the challenges of nucleic acid delivery by utilizing spherical nucleic acids (SNAs) that consist of densely packed polynucleotide strands attached to nanoparticles. The research demonstrates that G-rich SNAs have significantly higher cellular uptake compared to other nucleotide-rich SNAs, providing a promising strategy for enhancing intracellular delivery of therapeutics.
Career Highlights
Liangliang Hao has worked at prestigious institutions such as Northwestern University and the Massachusetts Institute of Technology. His work at these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Hao has collaborated with notable individuals, including Chad A. Mirkin and Kaylie L. Young, who are recognized for their contributions to nanotechnology and biomedical research.
Conclusion
Liangliang Hao's innovative patents and research efforts have significantly advanced the field of cancer detection and treatment. His work exemplifies the impact of scientific innovation on healthcare and the potential for future breakthroughs in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile